/ Print /

Leukemia and Lymphoma

New Payment Model Improves Cancer Care at Oncology GroupCEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
Burnout Hits Oncologists Hard, but Healthcare Systems Can Help
Burnout Hits Oncologists Hard, but Healthcare Systems Can HelpHealthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
Improve Care Coordination in Cancer Care: 2 Key Focus AreasWhen caring for cancer patients, improving care coordination in these two areas is key—and it can help reduce healthcare costs.
Seven diseases benefiting from genetic tests
Seven diseases benefiting from genetic testsGenetic testing is playing a growing role in diagnosing and treating diseases, particularly when it comes to certain cancers and rheumatic conditions.
Two Ways to Take Charge of CAR T-Cell Therapy CostsSuccessful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.
Top Considerations in Pediatric Cancer Treatment: What Payers Should KnowA Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be CloseIn partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
Five factors driving up the cost of oncology drugsThe high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
CAR T-cell therapies in treating lymphoma: Pros and consCatherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Three things health execs need to know about CAR T-cell therapyHere’s your quick guide to understanding how CAR T-cell therapy could affect patients and payers.